Ghaziabad Online

Research Antibodies Market Will Reach USD 5.33 Billion By 2027 at a Healthy CAGR of 5.9% – Reports and Data

 Breaking News
  • No posts were found

Research Antibodies Market Will Reach USD 5.33 Billion By 2027 at a Healthy CAGR of 5.9% – Reports and Data

September 23
21:06 2022
Research Antibodies Market Will Reach USD 5.33 Billion By 2027 at a Healthy CAGR of 5.9% - Reports and Data
Research Antibodies Market
The global research antibodies market is expected to reach USD 5.33 Billion by 2027, according to a new report by Reports and Data.

The global research antibodies market is expected to reach USD 5.33 Billion by 2027, according to a new report by Reports and Data. Rising research activities in the field of stem cells is a significant factor driving the growth of the market. Stem cells have the capability of discerning and regenerating various kinds of cells in the human body. These cells possess the potential to cure life-threatening diseases such as oncological and blood-related disorders. Cord blood stem cells find application in the treatment of more than 80 blood-related ailments, such as Sickle Cell Disease. It is projected that over 27 million babies across the globe are born with some kind of blood disorder. As per the World Health Organization, in 2008, 100,000 children were found to be suffering from thalassemia in India.

Increased funding for research and development activities is instrumental in driving the growth of the market. Investment in the healthcare R&D by the US has witnessed a growth of 18.1% between the years 2014 and 2017. In the year 2017, in the US, the overall expenditure on healthcare R&D was USD 182.30 billion. Besides, according to the 2016 financial statements of Celgene Corporation, a leading biopharmaceutical firm, the R&D expenditure grew by USD 772.8 million (21.0% more than 2015 expenses) in 2016 to USD 4.47 billion. Also, a USD 892.9 million of R&D asset acquisition spending, comprising a USD 625.0 million purchase of Engmab AG, a private firm engaged in T-cell bispecific antibodies, added to the overall R&D expenses of the Celgene.

However, cost-prohibitive research antibodies and issues related to the quality of nontherapeutic antibodies may create hindrances in the growth of the market in the upcoming years.

In April 2020, the ICMR (Indian Council of Medical Research) announced that it would fast-track funding proposals intended for immunology approaches for the treatment of coronavirus, a step to bridge the research gap in the country to combat the pandemic.

Further key findings from the report suggest:

  • By product, primary antibodies held a larger market share in 2019. Primary antibodies are those, which bind to the antigen, protein, or any substance that is intended to be studied. Primary antibodies, in immunoassays, are of prime importance to bind to the target antigen.
  •  
  • By technology, western blotting contributed to the largest market share in 2019. The benefits of western blots comprise the capacity to detect picogram levels of protein in a sample, enabling it to be used for several applications such as an effective early diagnostic tool. Also, it lets researchers for direct labeling of primary antibodies, therefore removing the requirement of secondary antibodies.
  •  
  • By application, oncology contributed to the largest market share in 2019. Antibody-based treatment of cancer is considered as an effective therapeutic approach for both hematologic solid tumors and malignancies. Antibodies are also beneficial in using the human immune system to fight cancer.
  •  
  • The market in the Asia Pacific region is expected to grow at the fastest rate of 7.1% in the forecast period. The high growth of the APAC region is owing to the growth of the pharmaceutical industry, surge in R&D activities for antibodies, and acceptance of innovative methods for antibody production, among others.
  •  
  • In January 2020, Abcam PLC, a leading market player, made an announcement about the acquisition of the Immunology and Proteomics business of Expedeon that comprises Innova and TGR Biosciences.

 

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3270

 

A surge in research activities in the field of neurobiology and stem cells is one of the significant factors influencing the market growth – Our Expert Opinion

Asia Pacific is expected to lead the market growth over the coming years owing to rapid advancements in the healthcare sector in APAC countries such as India, China, and Japan. North America is anticipated to register the highest market growth over the forecast period attributed to the increasing availability of robust healthcare and clinical settings, legalization of medical marijuana, favorable reimbursement scenario, presence of key market players, and rapid technological advancements in the region.

The growing popularity of over-the-counter medications driving market growth

Growing incidence of acute and chronic diseases and lesser access to advanced medical facilities owing to low disposable income levels are driving the demand for over-the-counter medications. Availability of generic and low-cost alternatives to medical therapies are some other factors playing a major role in driving demand for over-the-counter medications.

Restriction on product launches and R&D activities to hamper the market growth

The imposition of strict government regulations and shortage of funds has put a halt on product launches and R&D activities and is expected to restrain market growth over the forecast period. In addition, the launch of expensive drugs and therapies and increasing regulations regarding safety and approvals are also hampering the market growth.

 

Competitive Landscape:

The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, mergers and acquisitions, collaborations, and joint ventures to gain a robust footing in the market.

Top Companies Profiled in the Report:

Becton, Dickinson and Company, Lonza Group, Agilent Technologies, Abcam PLC, PerkinElmer, Inc., Bio-Rad Laboratories, Merck Millipore, F.Hoffmann-La Roche AG, Thermo Fisher Scientific, and Cell Signaling Technology Inc., among others.

Research Antibodies Market Segmentation:

Product Outlook (Revenue, USD Million; 2017-2027)

  • Primary Antibodies
  • Secondary Antibodies

 

Antibody Type Outlook (Revenue, USD Million; 2017-2027)

  • Monoclonal
  • Polyclonal

 

Technology Outlook (Revenue, USD Million; 2017-2027)

  • Western Blotting
  • Flow Cytometry
  • Immunofluorescence
  • Immunohistochemistry
  • Enzyme-linked Immunosorbent Assay
  • Immunoprecipitation
  • Others

 

Application Outlook (Revenue, USD Million; 2017-2027)

  • Oncology
  • Infectious Diseases
  • Stem Cells
  • Neurobiology
  • Immunology
  • Others

 

Regional Outlook:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
  • Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
  • Latin America (Brazil, Rest of LATAM)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of the Middle East & Africa)

 

Frequently asked questions addressed in the report:

  • What is the revenue growth rate of the global Research Antibodies market over the forecast period?
  • What are the major factors driving the growth of the Global Research Antibodies Market?
  • What are the key challenges impacting the global Research Antibodies market growth?
  • What are the outcomes of the SWOT Analysis and Porter’s Five Forces Analysis conducted in the report?

 

Thank you for reading our report. For more details please connect with us and our team will ensure the report is customized to meet all the needs of clients. The report also offers a comprehensive regional analysis and specific countries can be included in the report according to the requirements.

Explore Latest Trending Research Reports By Reports and Data:

Transdermal Skin Patch Market @ https://www.reportsanddata.com/report-detail/transdermal-skin-patch-market 

Cyclosporiasis Market @ https://www.reportsanddata.com/report-detail/cyclosporiasis-market 

Effervescent Tablet Market @ https://www.reportsanddata.com/report-detail/effervescent-tablet-market 

  About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Media Contact
Company Name: Reports and Data
Contact Person: John Watson
Email: Send Email
Phone: +1-212-710-1370
Address:40 Wall St. 28th floor
City: New York City
State: NY 10005
Country: United States
Website: https://www.reportsanddata.com/report-detail/research-antibodies-market